Rodman David Malcom, Chief Medical Officer of Mineralys Therapeutics ($MLYS), sold shares on the open market 28 times over the last year for a total of $13.4 million. His latest sale occurred on March 9, 2026. These MLYS insider sales rank 909th out of 11,678 individuals in our database, above the average of $8.6 million and 6.4 transactions. He reported no open market purchases.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 17, 2026 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Stock Option | 417 | $0.00 | 5,000.0000 | 79,139,956 | 7.70% | 0.00% |
| March 17, 2026 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | S | Common Stock | 417 | $25.65 | 76,140.0000 | 79,139,956 | 0.54% | 0.00% |
| March 17, 2026 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Common Stock | 417 | $15.44 | 76,557.0000 | 79,139,956 | 0.55% | 0.00% |
| March 13, 2026 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | S | Common Stock | 253 | $27.82 | 76,140.0000 | 79,139,956 | 0.33% | 0.00% |
| March 12, 2026 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Stock Option | 6348 | $0.00 | 25,395.0000 | 79,139,956 | 20.00% | 0.01% |
| March 13, 2026 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Stock Option | 3542 | $0.00 | 123,959.0000 | 79,139,956 | 2.78% | 0.00% |
| March 13, 2026 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Stock Option | 4167 | $0.00 | 95,834.0000 | 79,139,956 | 4.17% | 0.01% |
| March 12, 2026 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Common Stock | 6348 | $1.08 | 88,837.0000 | 79,139,956 | 7.70% | 0.01% |
| March 13, 2026 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | S | Common Stock | 10726 | $25.91 | 79,472.0000 | 79,139,956 | 11.89% | 0.01% |
| March 13, 2026 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | S | Common Stock | 3079 | $27.37 | 76,393.0000 | 79,139,956 | 3.87% | 0.00% |
| March 13, 2026 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Common Stock | 4167 | $14.25 | 90,198.0000 | 79,139,956 | 4.84% | 0.01% |
| March 13, 2026 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Common Stock | 3542 | $10.20 | 86,031.0000 | 79,139,956 | 4.29% | 0.00% |
| March 12, 2026 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | S | Common Stock | 6348 | $27.37 | 82,489.0000 | 79,139,956 | 7.15% | 0.01% |
| March 9, 2026 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | S | Common Stock | 2171 | $26.84 | 82,489.0000 | 79,139,956 | 2.56% | 0.00% |
| March 9, 2026 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Stock Option | 2171 | $0.00 | 23,876.0000 | 79,139,956 | 8.33% | 0.00% |
| March 9, 2026 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Common Stock | 2171 | $16.00 | 84,660.0000 | 79,139,956 | 2.63% | 0.00% |
| Feb. 19, 2026 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | A | Common Stock | 38400 | $0.00 | 82,489.0000 | 79,139,956 | 87.10% | 0.05% |
| Feb. 19, 2026 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | A | Stock Option | 51300 | $0.00 | 51,300.0000 | 79,139,956 | 9999.99% | 0.06% |
| Feb. 17, 2026 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Common Stock | 417 | $15.44 | 44,506.0000 | 79,139,956 | 0.95% | 0.00% |
| Feb. 17, 2026 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | S | Common Stock | 417 | $27.59 | 44,089.0000 | 79,139,956 | 0.94% | 0.00% |
| Feb. 17, 2026 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Stock Option | 417 | $0.00 | 5,417.0000 | 79,139,956 | 7.15% | 0.00% |
| Feb. 13, 2026 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | S | Common Stock | 6348 | $27.58 | 44,089.0000 | 79,139,956 | 12.59% | 0.01% |
| Feb. 13, 2026 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Stock Option | 4166 | $0.00 | 100,001.0000 | 79,139,956 | 4.00% | 0.01% |
| Feb. 13, 2026 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Stock Option | 3541 | $0.00 | 127,501.0000 | 79,139,956 | 2.70% | 0.00% |
| Feb. 12, 2026 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Stock Option | 6349 | $0.00 | 31,743.0000 | 79,139,956 | 16.67% | 0.01% |
| Feb. 13, 2026 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | S | Common Stock | 4166 | $27.33 | 50,437.0000 | 79,139,956 | 7.63% | 0.01% |
| Feb. 13, 2026 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Common Stock | 4166 | $14.25 | 54,603.0000 | 79,139,956 | 8.26% | 0.01% |
| Feb. 13, 2026 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | S | Common Stock | 3541 | $27.33 | 50,437.0000 | 79,139,956 | 6.56% | 0.00% |
| Feb. 13, 2026 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Common Stock | 3541 | $10.20 | 53,978.0000 | 79,139,956 | 7.02% | 0.00% |
| Feb. 12, 2026 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | S | Common Stock | 521 | $29.64 | 50,437.0000 | 79,139,956 | 1.02% | 0.00% |
| Feb. 12, 2026 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | S | Common Stock | 5828 | $28.94 | 50,958.0000 | 79,139,956 | 10.26% | 0.01% |
| Feb. 12, 2026 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Common Stock | 6349 | $1.08 | 56,786.0000 | 79,139,956 | 12.59% | 0.01% |
| Feb. 9, 2026 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Stock Option | 2171 | $0.00 | 26,047.0000 | 79,139,956 | 7.69% | 0.00% |
| Feb. 9, 2026 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | S | Common Stock | 2171 | $30.21 | 50,437.0000 | 79,139,956 | 4.13% | 0.00% |
| Feb. 9, 2026 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Common Stock | 2171 | $16.00 | 52,608.0000 | 79,139,956 | 4.30% | 0.00% |
| Jan. 20, 2026 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Stock Option | 416 | $0.00 | 5,834.0000 | 79,139,956 | 6.66% | 0.00% |
| Jan. 20, 2026 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | S | Common Stock | 416 | $32.10 | 50,437.0000 | 79,139,956 | 0.82% | 0.00% |
| Jan. 20, 2026 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Common Stock | 416 | $15.44 | 50,853.0000 | 79,139,956 | 0.82% | 0.00% |
| Jan. 13, 2026 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | S | Common Stock | 7709 | $32.75 | 61,804.0000 | 79,139,956 | 11.09% | 0.01% |
| Jan. 13, 2026 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Common Stock | 3542 | $10.20 | 65,346.0000 | 79,139,956 | 5.73% | 0.00% |
| Jan. 13, 2026 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Stock Option | 4167 | $0.00 | 104,167.0000 | 79,139,956 | 3.85% | 0.01% |
| Jan. 13, 2026 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Stock Option | 3542 | $0.00 | 131,042.0000 | 79,139,956 | 2.63% | 0.00% |
| Jan. 14, 2026 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | S | Common Stock | 11367 | $32.61 | 50,437.0000 | 79,139,956 | 18.39% | 0.01% |
| Jan. 13, 2026 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Common Stock | 4167 | $14.25 | 69,513.0000 | 79,139,956 | 6.38% | 0.01% |
| Jan. 12, 2026 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Common Stock | 6348 | $1.08 | 68,152.0000 | 79,139,956 | 10.27% | 0.01% |
| Jan. 9, 2026 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Common Stock | 2170 | $16.00 | 63,974.0000 | 79,139,956 | 3.51% | 0.00% |
| Jan. 12, 2026 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Stock Option | 6348 | $0.00 | 38,092.0000 | 79,139,956 | 14.28% | 0.01% |
| Jan. 9, 2026 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Stock Option | 2170 | $0.00 | 28,218.0000 | 79,139,956 | 7.14% | 0.00% |
| Jan. 12, 2026 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | S | Common Stock | 6348 | $32.32 | 61,804.0000 | 79,139,956 | 9.31% | 0.01% |
| Jan. 9, 2026 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | S | Common Stock | 2170 | $33.27 | 61,804.0000 | 79,139,956 | 3.39% | 0.00% |
| Jan. 5, 2026 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Stock Option | 26069 | $0.00 | 134,584.0000 | 79,139,956 | 16.23% | 0.03% |
| Jan. 2, 2026 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Stock Option | 3629 | $0.00 | 16,371.0000 | 79,139,956 | 18.15% | 0.00% |
| Jan. 2, 2026 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Stock Option | 10053 | $0.00 | 72,478.0000 | 79,139,956 | 12.18% | 0.01% |
| Jan. 5, 2026 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | S | Common Stock | 53470 | $35.53 | 61,804.0000 | 79,139,956 | 46.39% | 0.07% |
| Jan. 5, 2026 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | S | Common Stock | 139245 | $34.83 | 115,274.0000 | 79,139,956 | 54.71% | 0.18% |
| Jan. 5, 2026 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Common Stock | 67473 | $14.25 | 254,519.0000 | 79,139,956 | 36.07% | 0.09% |
| Jan. 5, 2026 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Common Stock | 53630 | $16.00 | 187,046.0000 | 79,139,956 | 40.20% | 0.07% |
| Jan. 5, 2026 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Common Stock | 26069 | $10.20 | 133,416.0000 | 79,139,956 | 24.28% | 0.03% |
| Jan. 5, 2026 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Common Stock | 10121 | $15.44 | 107,347.0000 | 79,139,956 | 10.41% | 0.01% |
| Jan. 5, 2026 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Common Stock | 28038 | $1.08 | 97,226.0000 | 79,139,956 | 40.52% | 0.04% |
| Jan. 2, 2026 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | S | Common Stock | 70037 | $35.87 | 69,188.0000 | 79,139,956 | 50.30% | 0.09% |
| Jan. 2, 2026 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Common Stock | 24193 | $14.25 | 139,225.0000 | 79,139,956 | 21.03% | 0.03% |
| Jan. 2, 2026 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Common Stock | 20168 | $16.00 | 115,032.0000 | 79,139,956 | 21.26% | 0.03% |
| Jan. 2, 2026 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Common Stock | 9347 | $10.20 | 94,864.0000 | 79,139,956 | 10.93% | 0.01% |
| Jan. 2, 2026 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Common Stock | 3629 | $15.44 | 85,517.0000 | 79,139,956 | 4.43% | 0.00% |
| Jan. 2, 2026 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Common Stock | 10053 | $1.08 | 81,888.0000 | 79,139,956 | 13.99% | 0.01% |
| Jan. 5, 2026 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Stock Option | 67473 | $0.00 | 108,334.0000 | 79,139,956 | 38.38% | 0.09% |
| Jan. 5, 2026 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Stock Option | 53630 | $0.00 | 30,388.0000 | 79,139,956 | 63.83% | 0.07% |
| Jan. 5, 2026 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Stock Option | 10121 | $0.00 | 6,250.0000 | 79,139,956 | 61.82% | 0.01% |
| Jan. 5, 2026 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Stock Option | 28038 | $0.00 | 44,440.0000 | 79,139,956 | 38.68% | 0.04% |
| Jan. 2, 2026 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Stock Option | 24193 | $0.00 | 175,807.0000 | 79,139,956 | 12.10% | 0.03% |
| Jan. 2, 2026 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Stock Option | 20168 | $0.00 | 84,018.0000 | 79,139,956 | 19.36% | 0.03% |
| Jan. 2, 2026 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Stock Option | 9347 | $0.00 | 160,653.0000 | 79,139,956 | 5.50% | 0.01% |
| Oct. 15, 2025 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | S | Common Stock | 10369 | $43.01 | 71,155.0000 | 49,835,637 | 12.72% | 0.02% |
| Sept. 15, 2025 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | S | Common Stock | 9302 | $35.90 | 83,589.0000 | 49,835,637 | 10.01% | 0.02% |
| Sept. 15, 2025 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | S | Common Stock | 2065 | $36.47 | 81,524.0000 | 49,835,637 | 2.47% | 0.00% |
| Aug. 12, 2025 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Stock Option | 6349 | $0.00 | 82,531.0000 | 49,835,637 | 7.14% | 0.01% |
| Aug. 12, 2025 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Common Stock | 6349 | $1.08 | 104,256.0000 | 49,835,637 | 6.48% | 0.01% |
| Aug. 13, 2025 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | S | Common Stock | 11365 | $12.93 | 92,891.0000 | 49,835,637 | 10.90% | 0.02% |
| July 14, 2025 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | S | Common Stock | 11366 | $14.59 | 97,907.0000 | 49,835,637 | 10.40% | 0.02% |
| July 14, 2025 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Stock Option | 6349 | $0.00 | 88,880.0000 | 49,835,637 | 6.67% | 0.01% |
| July 14, 2025 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Common Stock | 6349 | $1.08 | 109,273.0000 | 49,835,637 | 6.17% | 0.01% |
| June 12, 2025 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Common Stock | 6348 | $1.08 | 113,017.0000 | 49,835,637 | 5.95% | 0.01% |
| June 13, 2025 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | S | Common Stock | 11366 | $14.60 | 101,651.0000 | 49,835,637 | 10.06% | 0.02% |
| June 12, 2025 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Stock Option | 6348 | $0.00 | 95,229.0000 | 49,835,637 | 6.25% | 0.01% |
| May 14, 2025 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | S | Common Stock | 11366 | $15.29 | 106,669.0000 | 49,835,637 | 9.63% | 0.02% |
| May 12, 2025 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Stock Option | 6349 | $0.00 | 101,577.0000 | 49,835,637 | 5.88% | 0.01% |
| May 12, 2025 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Common Stock | 6349 | $1.08 | 118,035.0000 | 49,835,637 | 5.68% | 0.01% |
| April 14, 2025 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Common Stock | 6348 | $1.08 | 123,052.0000 | 49,835,637 | 5.44% | 0.01% |
| April 14, 2025 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | S | Common Stock | 2966 | $13.69 | 120,086.0000 | 49,835,637 | 2.41% | 0.01% |
| April 14, 2025 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | S | Common Stock | 8400 | $14.83 | 111,686.0000 | 49,835,637 | 6.99% | 0.02% |
| April 14, 2025 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Stock Option | 6348 | $0.00 | 107,926.0000 | 49,835,637 | 5.56% | 0.01% |
| April 1, 2025 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Stock Option | 1606 | $0.00 | 114,274.0000 | 49,835,637 | 1.39% | 0.00% |
| April 1, 2025 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | S | Common Stock | 30574 | $15.00 | 141,901.0000 | 49,835,637 | 17.73% | 0.06% |
| April 1, 2025 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Common Stock | 1606 | $1.08 | 172,475.0000 | 49,835,637 | 0.94% | 0.00% |
| April 1, 2025 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | S | Common Stock | 2791 | $16.02 | 139,110.0000 | 49,835,637 | 1.97% | 0.01% |
| April 1, 2025 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | S | Common Stock | 22406 | $16.77 | 116,704.0000 | 49,835,637 | 16.11% | 0.04% |
| March 12, 2025 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Stock Option | 6349 | $0.00 | 115,880.0000 | 49,835,637 | 5.19% | 0.01% |
| March 12, 2025 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Common Stock | 6349 | $1.08 | 170,869.0000 | 49,835,637 | 3.86% | 0.01% |
| Feb. 13, 2025 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | A | Stock Option | 170000 | $0.00 | 170,000.0000 | 49,835,637 | 9999.99% | 0.34% |
| Feb. 12, 2025 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Common Stock | 6348 | $1.08 | 164,520.0000 | 49,835,637 | 4.01% | 0.01% |
| Feb. 12, 2025 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Stock Option | 6348 | $0.00 | 122,229.0000 | 49,835,637 | 4.94% | 0.01% |
| Jan. 13, 2025 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Stock Option | 5018 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Jan. 13, 2025 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Common Stock | 5018 | $0.54 | 151,823.0000 | 0 | 3.42% | 0.00% |
| Jan. 13, 2025 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Common Stock | 6349 | $1.08 | 158,172.0000 | 0 | 4.18% | 0.00% |
| Jan. 13, 2025 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Stock Option | 6349 | $0.00 | 128,577.0000 | 0 | 4.71% | 0.00% |
| Dec. 11, 2024 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Common Stock | 5017 | $0.54 | 146,008.0000 | 0 | 3.56% | 0.00% |
| Dec. 11, 2024 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Stock Option | 5017 | $0.00 | 5,018.0000 | 0 | 50.00% | 0.00% |
| Nov. 11, 2024 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Stock Option | 5026 | $0.00 | 134,926.0000 | 0 | 3.59% | 0.00% |
| Nov. 11, 2024 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Common Stock | 5017 | $0.54 | 140,991.0000 | 0 | 3.69% | 0.00% |
| Nov. 11, 2024 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Common Stock | 5026 | $1.08 | 146,017.0000 | 0 | 3.56% | 0.00% |
| Nov. 11, 2024 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | S | Common Stock | 5026 | $15.00 | 140,991.0000 | 0 | 3.44% | 0.00% |
| Nov. 11, 2024 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Stock Option | 5017 | $0.00 | 10,035.0000 | 0 | 33.33% | 0.00% |
| Nov. 6, 2024 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Stock Option | 25482 | $0.00 | 139,952.0000 | 0 | 15.40% | 0.00% |
| Nov. 6, 2024 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Common Stock | 25482 | $1.08 | 161,456.0000 | 0 | 18.74% | 0.00% |
| Nov. 6, 2024 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | S | Common Stock | 25482 | $15.03 | 135,974.0000 | 0 | 15.78% | 0.00% |
| Oct. 14, 2024 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Stock Option | 5352 | $0.00 | 165,434.0000 | 0 | 3.13% | 0.00% |
| Oct. 11, 2024 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Common Stock | 5017 | $0.54 | 130,622.0000 | 0 | 3.99% | 0.00% |
| Oct. 14, 2024 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Common Stock | 5352 | $1.08 | 135,974.0000 | 0 | 4.10% | 0.00% |
| Oct. 11, 2024 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Stock Option | 5017 | $0.00 | 15,052.0000 | 0 | 25.00% | 0.00% |
| Sept. 11, 2024 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Stock Option | 5018 | $0.00 | 20,069.0000 | 0 | 20.00% | 0.00% |
| Sept. 11, 2024 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Common Stock | 5018 | $0.54 | 119,256.0000 | 0 | 4.39% | 0.00% |
| Sept. 12, 2024 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Common Stock | 6349 | $1.08 | 125,605.0000 | 0 | 5.32% | 0.00% |
| Sept. 12, 2024 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Stock Option | 6349 | $0.00 | 170,786.0000 | 0 | 3.58% | 0.00% |
| Aug. 12, 2024 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Stock Option | 5017 | $0.00 | 25,087.0000 | 0 | 16.67% | 0.00% |
| Aug. 12, 2024 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Common Stock | 5017 | $0.54 | 107,890.0000 | 0 | 4.88% | 0.00% |
| Aug. 12, 2024 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Common Stock | 6348 | $1.08 | 114,238.0000 | 0 | 5.88% | 0.00% |
| Aug. 12, 2024 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Stock Option | 6348 | $0.00 | 177,135.0000 | 0 | 3.46% | 0.00% |
| July 16, 2024 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | S | Common Stock | 525 | $15.00 | 102,873.0000 | 0 | 0.51% | 0.00% |
| July 16, 2024 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Common Stock | 525 | $1.08 | 103,398.0000 | 0 | 0.51% | 0.00% |
| July 16, 2024 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Stock Option | 525 | $0.00 | 183,483.0000 | 0 | 0.29% | 0.00% |
| July 12, 2024 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Common Stock | 6349 | $1.08 | 102,873.0000 | 0 | 6.58% | 0.00% |
| July 11, 2024 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Common Stock | 5017 | $0.54 | 96,524.0000 | 0 | 5.48% | 0.00% |
| July 12, 2024 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Stock Option | 6349 | $0.00 | 184,008.0000 | 0 | 3.34% | 0.00% |
| July 11, 2024 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Stock Option | 5017 | $0.00 | 30,104.0000 | 0 | 14.28% | 0.00% |
| June 11, 2024 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Common Stock | 5017 | $0.54 | 83,380.0000 | 0 | 6.40% | 0.00% |
| June 12, 2024 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Stock Option | 6349 | $0.00 | 190,357.0000 | 0 | 3.23% | 0.00% |
| June 11, 2024 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Stock Option | 5017 | $0.00 | 35,121.0000 | 0 | 12.50% | 0.00% |
| June 12, 2024 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Common Stock | 6349 | $1.08 | 89,729.0000 | 0 | 7.61% | 0.00% |
| May 13, 2024 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Stock Option | 5018 | $0.00 | 40,138.0000 | 0 | 11.11% | 0.00% |
| May 13, 2024 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Common Stock | 5018 | $0.54 | 72,015.0000 | 0 | 7.49% | 0.00% |
| May 13, 2024 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Common Stock | 6348 | $1.08 | 78,363.0000 | 0 | 8.81% | 0.00% |
| May 13, 2024 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Stock Option | 6348 | $0.00 | 196,706.0000 | 0 | 3.13% | 0.00% |
| May 9, 2024 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | S | Common Stock | 100 | $15.00 | 66,997.0000 | 0 | 0.15% | 0.00% |
| May 9, 2024 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Common Stock | 100 | $1.08 | 67,097.0000 | 0 | 0.15% | 0.00% |
| May 9, 2024 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Stock Option | 100 | $0.00 | 203,054.0000 | 0 | 0.05% | 0.00% |
| April 11, 2024 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Stock Option | 5017 | $0.00 | 45,156.0000 | 0 | 10.00% | 0.00% |
| April 11, 2024 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Common Stock | 5017 | $0.54 | 60,648.0000 | 0 | 9.02% | 0.00% |
| April 12, 2024 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Common Stock | 6349 | $1.08 | 66,997.0000 | 0 | 10.47% | 0.00% |
| April 12, 2024 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Stock Option | 6349 | $0.00 | 203,154.0000 | 0 | 3.03% | 0.00% |
| March 12, 2024 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Stock Option | 6348 | $0.00 | 209,503.0000 | 0 | 2.94% | 0.00% |
| March 11, 2024 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Common Stock | 5017 | $0.54 | 49,283.0000 | 0 | 11.33% | 0.00% |
| March 12, 2024 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Common Stock | 6348 | $1.08 | 55,631.0000 | 0 | 12.88% | 0.00% |
| March 11, 2024 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Stock Option | 5017 | $0.00 | 50,173.0000 | 0 | 9.09% | 0.00% |
| Feb. 13, 2024 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | A | Stock Option | 200000 | $0.00 | 200,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 12, 2024 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Stock Option | 5017 | $0.00 | 55,190.0000 | 0 | 8.33% | 0.00% |
| Feb. 12, 2024 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Common Stock | 6349 | $1.08 | 44,266.0000 | 0 | 16.74% | 0.00% |
| Feb. 12, 2024 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Common Stock | 5017 | $0.54 | 37,917.0000 | 0 | 15.25% | 0.00% |
| Feb. 12, 2024 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Stock Option | 6349 | $0.00 | 215,851.0000 | 0 | 2.86% | 0.00% |
| Jan. 11, 2024 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Common Stock | 5017 | $0.54 | 26,552.0000 | 0 | 23.30% | 0.00% |
| Jan. 12, 2024 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Stock Option | 6348 | $0.00 | 222,200.0000 | 0 | 2.78% | 0.00% |
| Jan. 11, 2024 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Stock Option | 5017 | $0.00 | 60,207.0000 | 0 | 7.69% | 0.00% |
| Jan. 12, 2024 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Common Stock | 6348 | $1.08 | 32,900.0000 | 0 | 23.91% | 0.00% |
| Dec. 11, 2023 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Common Stock | 5018 | $0.54 | 20,069.0000 | 0 | 33.34% | 0.00% |
| Dec. 11, 2023 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Stock Option | 5018 | $0.00 | 65,224.0000 | 0 | 7.14% | 0.00% |
| Nov. 13, 2023 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Stock Option | 5017 | $0.00 | 70,242.0000 | 0 | 6.67% | 0.00% |
| Nov. 13, 2023 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Common Stock | 5017 | $0.54 | 15,051.0000 | 0 | 50.00% | 0.00% |
| Nov. 3, 2023 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Stock Option | 10034 | $0.00 | 75,259.0000 | 0 | 11.76% | 0.00% |
| Nov. 3, 2023 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Common Stock | 10034 | $0.54 | 10,034.0000 | 0 | 9999.99% | 0.00% |
| Aug. 10, 2023 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | S | Common Stock | 74625 | $13.16 | 0.0000 | 0 | 100.00% | 0.00% |
| Aug. 11, 2023 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Common Stock | 76182 | $1.08 | 76,182.0000 | 0 | 9999.99% | 0.00% |
| Aug. 11, 2023 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | S | Common Stock | 76182 | $12.81 | 0.0000 | 0 | 100.00% | 0.00% |
| Aug. 10, 2023 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Stock Option | 74625 | $0.00 | 166,202.0000 | 0 | 30.99% | 0.00% |
| Aug. 11, 2023 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Stock Option | 80909 | $0.00 | 85,293.0000 | 0 | 48.68% | 0.00% |
| Aug. 11, 2023 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Stock Option | 76182 | $0.00 | 228,548.0000 | 0 | 25.00% | 0.00% |
| Aug. 11, 2023 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Common Stock | 80909 | $0.54 | 80,909.0000 | 0 | 9999.99% | 0.00% |
| Aug. 10, 2023 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | M | Common Stock | 74625 | $0.54 | 74,625.0000 | 0 | 9999.99% | 0.00% |
| Aug. 11, 2023 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | S | Common Stock | 80909 | $12.81 | 0.0000 | 0 | 100.00% | 0.00% |
| March 17, 2023 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | A | Stock Option | 20000 | $0.00 | 20,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 9, 2023 | Mineralys Therapeutics, Inc. | $MLYS | Rodman David Malcom | Chief Medical Officer | A | Stock Option | 104186 | $0.00 | 104,186.0000 | 0 | 9999.99% | 0.00% |